Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease

NCT07641140 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Lingyi Biotech Co., Ltd.